James S. Ely III - 02 May 2023 Form 4 Insider Report for SELECT MEDICAL HOLDINGS CORP (SEM)

Reporting relationship: Director
Issuer ticker: SEM
Reported as of: 02 May 2023
Net transaction value: +$18,013
SEC form: 4
Accepted by SEC: 03 May 2023, 17:39:25 UTC
Prior SEC filing: 02 Mar 2023
Next SEC filing: 02 Aug 2023
Source filing: View source filing
Reporting owner signature: /s/ Michael E. Tarvin, Attorney-in-Fact

Key filing fact

James S. Ely III filed Form 4 for SELECT MEDICAL HOLDINGS CORP (SEM) on 03 May 2023.

Key facts

This page summarizes James S. Ely III's Form 4 filing for SELECT MEDICAL HOLDINGS CORP (SEM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 May 2023, 17:39.

Change

Previous filing in this sequence was filed on 02 Mar 2023.
Current net transaction value: +$18,013.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SEM transaction

Common Stock

Award

Transaction value: $18,013
Shares: +615
Change %: +0.49%
Price: $29.29
Shares after: 126,239
Date: 02 May 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000.